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It has been found that mono- and especially diphenazinium derivatives of oligonucleotides complementary to the DNA 
sequence adjacent to the target sequence of the addressed alkylation of DNA, significantly enhance the extent and speci- 
ficity of alkylation with p-(N-2-chloroethyl-Nmethylamino)benzylamide derivatives of the addressing oligonucleotides, 
thus playing the role of effector of the sequence-specific (complementary addressed) modification. 
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1. INTRODUCTION 
Modification of nucleic acids in the vicinity of 
definite sequences with reactive derivatives of 
oligonucleotides complementary to these se- 
quences was proposed over 20 years ago by N.I. 
Grineva as a general approach to sequence-specific 
(‘complementary addressed’) modification of the 
nucleic acid strands [l-3]. Most of the investiga- 
tion was carried out using derivatives bearing 
the N-2-chloroethyl-iV-methylaminophenyl (CIR) 
group. These derivatives were shown to alkylate 
single-stranded DNA fragments in the regions ad- 
jacent to the target sequences [4,5]. However, 
definite indications were obtained that reaction 
may proceed to some extent in the regions of in- 
complete complementarity of the target sequences 
and oligonucleotide moiety (address) of the 
reagent [6]. Obviously the variety of such regions 
should increase with the growth of the length of 
the addressing moiety. At the same time short 
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Sciences, 630090 Novosibirsk, USSR derivatives I-VI used are presented in fig.1. Starting 
oligonucleotides do not form duplexes of sufficient 
stability and the extent of modification by their 
derivatives is low [5]. The reaction yield may be 
enhanced by binding some duplex stabilizing 
radical, e.g. phenazinium to the terminal residue 
of the addressing oligonucleotide opposite the 
location of the reactive group [5,6]. 
In the present paper we describe another ap- 
proach to enhancement of the extent and specifici- 
ty of the sequence-specific alkylation of 
single-stranded DNA with reagents having short 
oligonucleotide address. It is based upon the 
lengthening of the double-stranded region formed 
by DNA and reagent with ‘effector’ 
oligonucleotide complementary to the DNA se- 
quence adjacent to the target one. To make the 
nicked duplex formed more stable, phenazinium 
derivatives of the effector oligonucleotide were 
used. 
2. MATERIALS AND METHODS 
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oligonucleotides containing either 5 ’ -phosphate (for the 
preparation of reagents I, 11 and derivatives III and V) or both 
3’- and 5 ‘-phosphates (for the preparation of reagents V and 
VI) were prepared by the solid phase phosphoramidite pro- 
cedure using automated synthesator Victoria 4M, USSR [7]. 
Terminal monophosphate groups were introduced by conver- 
sion of uridine-5 ‘-phosphate r sidues by periodate oxidation 
and subsequent &elimination as described [8]. To prepare 
oligonucleotide containing these residues (iPr)aN-P(OCHs)- 
OU(B& was used at the last step and (DMTr)U(Ac) at the first 
step of the oligonucleotide synthesis. The structure of 
oligonucleotides was confirmed by the Maxam-Gilbert pro- 
cedure [9]. N-hydroxyethylphenazinium (Phn) and p- 
(N-2-chloroethyl-N-methylamino)benzylamide (CIRCHzNH) 
residues were attached to phosphates using the phosphate ac- 
tivation procedure described in [6,10]. Concentration of the 
derivatives used was measured spectrophotometrically, taking 
molar extinction as the sum of molar extinctions of 
oligonucleotide and respective radicals (~260 = 14.7 x lo3 M-’ 
cm-’ for Phn and 6260 = 10 x 10’ M-’ cm-’ for ClRCHzNH). 
Aikyiation conditions and treatment of the specimens are 
described in the legends to figs 2 and 3. 
3. RESULTS 
Single-stranded DNA fragment 303 nucleotides 
RePion A 
B Revlon 
160 TT 170 6A 
CAGAGTCCTCCCGGliGCT 
ACCCAG~G~~~W#~CA 
150 , , I I I ‘),40.\\” 
L 
(I) llllII,l lllIIllI 
Phn-BHCB,CH$lI-d( pGAGCGTGG) 
P~~_IsHcH~CH$H-~(~GAGCC~GG) 
Fig. 1. The structures of the target regions of the DNA fragment, reagents and effecters used. Broken lines represent tentative hydrogen 
bondings. 
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in length described in [5] was used in this investiga- 
tion. The fragment contains two identical 
oligonucleotide sequences TGGGAA in positions 
144-149 and 261-266. The regions adjoining these 
sequences and their tentative secondary structure 
estimated according to [ 1 l] are presented in fig. 1, 
as well as the reagents used and phenazinium 
A 
123456: 
Fig.2. Autoradiogram of the 8% denaturating polyacrylamide 
gel-electrophoresis of 3’ 32 P-labeled DNA fragment modified 
by reagent I after 10% piperidine treatment at 100°C for 
30 min. Modifications were carried out in 0.16 M NaCI, 
0.1 mM EDTA, 0.02 M Na2P04, pH 7.4, t = 37”C, time = 
18 h, [DNA] = 1 x 1O-8 M, [I], [III], [IV], [VI, [VI] = 1.7 x 
1O-5 M). Reaction probes additionally contained the following: 
lane 1: I and III; lane 2: I and IV; lane 3: none; lane 4: I; lane 
5: I and V; lane 6: I and VI. 
oligonucleotide derivatives tried as potential effec- 
tors. The latter contain oligonucleotide moieties 
complementary, respectively, to sequences 
136-143 and 253-260 adjacent upstream to 
TGGGAA fragments. 
No alkylation was observed at 37°C after treat- 
ment of 10m8 M fragment with 1.7 x 10v5 M of 
reagent I (fig.2, lane 4). Addition to the same reac- 
tion mixture of an equimolar amount of III 
resulted in the appearance of a slight alkylation of 
Gz6’ (fig.2, lane 1). Addition of the same amount 
of IV resulted in significant alkylation of Gz6’ and 
some alkylation of G263 and G264 (fig.2, lane 2). 
No reaction was observed in this region upon addi- 
tion of VI. In the presence of the latter 
diphenazinium derivative definite alkylation in the 
oligopurinic region G145GGAAGA”1 was also 
found (fig.2, lane 6). Modification level calculated 
as the ratio of radioactivity of the spots in the 
modification area to the sum of the counts of these 
spots and the spot at the start for diphenazinium 
derivatives III and VI were found to be 45 and 
25070, respectively. Being related to the total 
radioactivity of the gel these values are significant- 
ly lower (14 and 5%, respectively). 
The quantitative dependence of the modification 
extent on the effector concentration was studied 
using reagent II and monophenazinium derivative 
III. In this case alkylation proceeded mainly at 
G269. The results are presented in fig.3. It is seen 
that at a concentration of reagent II insufficient 
for any measurable alkylation in the absence of ef- 
fector nearly complete alkylation may be achieved 
by increase of the effector concentration up to 
1O-4 M. 
Fig.3. The dependence of the DNA fragment modification 
extent by reagent II on concentration of effector III [DNA] = 
1 x 10-s M, [II] = 1 x 10m5 M, t = 25°C (0), 37’C (x). The 
modification extents were calculated as the ratio of 
radioactivity of the spot of product to the sum of radioactivities 
of the spots of product and the unchanged DNA fragment. 
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4. DISCUSSION 
It is shown that the modification yield and 
specificity of the complementary addressed alkyla- 
tion of DNA with oligonucleotide derivatives con- 
taining aromatic 2-chloroethylamino group may be 
increased significantly by phenazinium oligo- 
nucleotide derivatives lengthening the duplex 
formed by addressing part of the reagent and 
target sequence of DNA. Thus these derivatives 
may be considered as effecters (activators) of such 
modification. Specificity is enhanced since both 
complete and incomplete complexes formed by ef- 
fector outside the target region, do not lead to 
modification due to the absence of reactive group, 
whereas complexes formed by reagent outside this 
region are insufficiently stable to result in 
measurable xtent of alkylation due to the absence 
of adjacent effector. It is noteworthy that addition 
of effecters V and VI permitted alkylation of 
guanines to be carried out within the stem of ten- 
tative hairpin which never were found to be 
modified by previously studied reagents [5]. 
Therefore, it may be expected that the use of effec- 
tors would permit sequence-specific modification 
to be performed within double-stranded regions of 
DNA molecules. Although demonstrated for 
alkylation, the approach does not seem to depend 
on the nature of the reactive group and we believe 
that it will be useful for the other types of reactions 
used for the sequence specific modification of 
nucleic acids. 
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